← FDA Drug Approvals (Drugs@FDA)
DANTROLENE SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA SPECLTS · Approved 2016-02-18
Drug application
- FDA Application #
ANDA205239- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DANTROLENE SODIUM
- Generic name
- Dantrolene Sodium
- Active ingredients
- DANTROLENE SODIUM
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- EUGIA PHARMA SPECLTS
- First approval
- 2016-02-18
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown